2022
DOI: 10.1080/00365521.2022.2090854
|View full text |Cite
|
Sign up to set email alerts
|

EMR-P for small rectal neuroendocrine tumors: is it a preferred treatment?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 14 publications
0
1
0
Order By: Relevance
“…10 At initial diagnosis, R-NETs are more often small, localized lesions, with a low risk of distal metastasis; thus, the prognosis is good, with an overall 5-year survival rate >75%. 21 The detection rate of R-NETs has increased with the improvement of physicians' knowledge of R-NETs, the popularization of endoscopy screening and surveillance, and the development of endoscopic ultrasound technology. Consequently, questions have arisen regarding the optimal therapeutic approach.…”
Section: Discussionmentioning
confidence: 99%
“…10 At initial diagnosis, R-NETs are more often small, localized lesions, with a low risk of distal metastasis; thus, the prognosis is good, with an overall 5-year survival rate >75%. 21 The detection rate of R-NETs has increased with the improvement of physicians' knowledge of R-NETs, the popularization of endoscopy screening and surveillance, and the development of endoscopic ultrasound technology. Consequently, questions have arisen regarding the optimal therapeutic approach.…”
Section: Discussionmentioning
confidence: 99%